What are the risks of investing in REGN?
R
What are the risks of investing in REGN?
🦉
Regeneron Pharmaceuticals, Inc. (REGN)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOLeonard S. Schleifer
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal...
Key Executives
| Name | Title |
|---|---|
| Andrew J. Murphy | Executive Vice President of Research & Co-Chief Scientific Officer |
| Christopher R. Fenimore | Executive Vice President of Finance & Chief Financial Officer |
| Daniel Van Plew | Executive Vice President and GM of Industrial Operations & Product Supply |
| George D. Yancopoulos | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
| Hanne Bak | Senior Vice President of Product, Analytical & Process Development |
| John Lin | Senior VP of Antibody Technology, Oncology & Research |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A